Several genetic defects in class switch recombination, which lead to a hyper-IgM syndrome, have been described recently in humans. In addition to the well known role of CD40-ligand-CD40 interaction, these pathologies demonstrate definitively the requirement of CD40-mediated nuclear factor KB activation and the essential role of a recently described molecule, the activationinduced cytidine deaminase in an efficient humoral response, which includes class switch recombination and the production of high-affinity antibodies.
Introduction
T h e generation of the antibody repertoire requires two successive steps. T h e first step is antigen-and T-cell-independent, and takes place in the foetal liver and the bone marrow. Immature B-lymphocytes rearrange their immunoglobulin V (variKey words: activation-induced cytidine deaminase B-lymphocyte maturation, CD40-CD40-ligand interaction, germinal centre. Abbreviations used : AID, activation-induced cytidine deaminase; apoB, apolipoprotein B; APOBEC-I, apoB RNA-editing enzyme I ; C region, Ig constant region: CD40-L, CD40-ligand; CSR, class switch recombination; ds, double-stranded; HIGM, hyper-lgM; NEMO, NF-KB essential modulator; NF-KB, nuclear factor KB: S region, Ig switch region: SHM. somatic hypermutation; V region, Ig variable region. 'E-mail durandy(u)necker.fr able), D (diversity) and J (joining) gene segments, which produces a functionally integrated VD J segment that is linked to the p constant region (Cp). A primary antibody repertoire, composed of IgM antibodies, is thus generated. T h e second step is antigen-and T-cell-dependent and takes place in secondary lymphoid organs. After encountering antigen, which they recognize via their membrane IgM, B-cells proliferate and form germinal centres. In this unique anatomic formation, two genetic events lead to the generation of the secondary antibody repertoire. T h e first event, immunoglobulin class switch recombination (CSR), occurs by a recombination process between two different switch (S) regions that are located upstream of each C region. Replacement of the C region C p by a C region of another class of immunoglobulin (Cy, C a or CE) leads to the production of IgG, IgA and IgE molecules which harbour the same V specificity [l] . T h e second genetic event involves somatic hypermutations (SHMs), i.e. mutations located in the genes that encode the V regions of the immunoglobulin; this step precedes the positive selection of B-cells that harbour a B-cell receptor with high affinity for antigen and the negative selection of B-cells carrying a B-cell receptor with a low affinity for antigen or specific for an auto-antigen. These selection processes occur within the germinal centres in close interaction with follicular den-
Role of CD40-CD40-ligand (CD40-L) interaction in CSR
T h e hyper-IgM (HIGM) syndrome that was described first was the X-linked form, which results from mutations in the gene encoding CD40-L ( H I G M l syndrome) [3-71. CD40-L is expressed by activated helper T-cells and interacts with CD40, which is constitutively expressed on the surface of B-cells, monocytes and dendritic cells. As a consequence of a trans CD40 activation defect, patients' B-cells are unable to proliferate and form germinal centres in lymphoid organs, and to undergo CSR in vivo. T h e defective IgG and IgA production is responsible for an increased susceptibility to bacterial infections. Impaired CD40-L expression also results in a defective interaction of T-cells with monocytes/ dendritic cells, which leads to an abnormal cellular immune response, the consequence of which is a severe susceptibility to opportunistic infections, which cannot be prevented by intravenous immunoglobulin substitution [8] .
Interestingly, it has been reported recently that the few IgM+/IgD+-B-cells from H I G M l patients that express the marker CD27, which is specific for memory B-cells, carry SHMs [9] . T h e presence of this unswitched, mutated B-cell population suggests that SHMs can occur even in the absence of the classical CD40-L-CD40 interaction, which raises the issue of a second B-cell diversification pathway, the molecular determination of which is still unknown.
A recent report [lo] described three patients in two consanguineous families suffering from HIGM3, who had the same susceptibility to bacterial and opportunistic infections as is observed in H I G M l patients. The lack of CSR was found not to be due to a CD40-L expression deficiency which has been reported in some female patients because of skewing in X chromosome inactivation [ l 11. T h e patients' B-cells and monocytes failed to express the CD40 molecules because of two different homozygous mutations in the CD40 gene. However, in contrast with H I G M l patients, patients' B-cells do not express CD27 molecules and do not harbour SHMs. All these observations demonstrate the essential role that CD40-L-CD40 interaction and the CD40-induced NF-KB pathway play in B-cell terminal differentiation, and especially in CSR.
Role of CD40-mediated nuclear factor KB (NF-KB) activation in CSR

Role of activation-induced cytidine deaminase (AID) in CSR and the generation of SHMs
Another H I G M syndrome, with autosomal recessive inheritance (HIGM2), has been described [17, 18] . These patients are affected with a peculiar susceptibility to bacterial infections, but not to opportunistic infections. All patients exhibit markedly diminished serum IgA and IgG levels, with a normal or increased level of serum IgM. B-cells reveal an intrinsic defect since they do not undergo CSR in vitro in the presence of CD40 agonists and appropriate cytokines [18] . In addition, patients' B-cells, although the CD27 marker is expressed normally, exhibit very few if any SHMs. Thus, characteristics of HIGM2 syndrome include not only a lack of CSR, but also a defective generation of SHMs [19] .
Another feature of the syndrome is the enlargement of secondary lymphoid organs due to the presence of giant germinal centres filled with proliferating B-lymphocytes that co-express IgM, IgD and CD38, a phenotype described previously as characteristic of the germinal centre founder cell subset [20] .
This peculiar H I G M syndrome has been related to deleterious mutations in the gene encoding AID, a molecule that is only expressed in B-cells undergoing CSR and SHM in vivo [21] and in vitro [22] .
Interestingly, this protein is structurally related (34 o/ o similarity) with the apolipoprotein B (apoB) RNA-editing enzyme (APOBEC-1). RNA editing is widely used to create new functional proteins from the restricted genomes in plants and protozoa [23, 24] . An increasing number of mammalian mRNAs are also known to be edited, including apoB mRNA, which is edited by APOBEC-1. ApoB mRNA editing involves a sitespecific C+U deamination of the first base of a CAA codon encoding G1u2l5' of apoB100, and produces a UAA in-frame stop codon in apoB48 mRNA. ApoBlOO and apoB48 are translation products of the unedited and edited apoB mRNA respectively, and these proteins exert completely different functions with different expression patterns (owing to tissue-specific expression of APOBEC-1). Because of its similarity with APOBEC-1 and its cytidine deaminase activity in zitro, it is likely that AID acts as an actual RNAediting enzyme; however, its precise role, which appears to be essential in B-cell maturation, as shown by humoral immune deficiency in H I G M 2 patients, is unknown at present.
T h e phenotype of H I G M 2 patients suggests that A I D exerts its activity on a common substrate that is required for both CSR and S H M . There is some evidence that CSR and S H M , although able to occur independently, could share a part of the genetic alteration machinery, since mutations are frequently found in the S regions [25, 26] , as well as in the V regions.
It is known that both events require transcription of the target DNA [27, 28] ; however, it is likely that A I D plays a role downstream of the transcription step since sterile germline IE-CE transcripts, induced by CD40 agonists and interleukin-4, can be detected in activated B-cells from H I G M 2 patients [19] . Several groups have concomitantly demonstrated the occurrence of double-stranded (ds) DNA breaks occurring during the S H M process [29, 30] , as is strongly suggested in CSR [31] . Some recent data demonstrate that ds DNA breaks occur normally during S H M in AID-deficient B-cells [32] . It has also been shown recently that ds DNA repair proteins (phosphorylated histone 2AX and Nijmegen breakage syndrome protein 1) [33] are not normally recruited for CSR in B-cells after activation in A I D --mice [34] . Both observations suggest a defect in the very early event of DNA repair, even before the recruitment of histone 2AX and Nbs-1 proteins.
Other proteins involved in DNA repair have been studied largely in the CSR and S H M processes. T h e role of non-homologous endjoining enzymes (DNA protein kinase and the Ku70-Ku80 recombination complex) has been established in CSR [35, 36] , whereas they are not required for S H M [37] . T h e mismatched repair enzymes were also shown to play, at varying levels, a role in . T h e nucleotide excision repair enzyme, although it has been shown to induce cleavage of S regions in vitro [43] , seems to have no actual activity in vivo [44] . Errorprone polymerases, such as Pol-9 and Pol-(, the requirement for which is already shown in S H M [45-471, could also be involved in DNA repair during CSR, according to the high levels of mutations observed in recombined S regions.
Another hypothesis is to consider A I D as a DNA-editing enzyme. As suggested in a recent review, A I D might function as a nick-inducer by deaminating of C to form U at the DNA level in V regions and S regions, thereby leading to ds DNA breaks, which therefore become substrates for error-prone DNA repair enzymes [48] . Thus, the description of H I G M 2 patients gives evidence for the role of the A I D molecule in B-cell terminal differentiation and strongly suggests that S H M and CSR share a, as yet undefined, common mechanism.
Other HIGM syndromes
We have observed patients with a clinical phenotype similar to that observed in HIGM2, including enlarged lymph nodes, but who have normal A I D sequence and expression [49] . T h e immunological study of these patients gives evidence for a defective CSR in vivo and in vitro that leads to the H I G M syndrome. T h e patients display a normal generation of SHMs, suggesting that a target or a co-factor of AID, which is specific to CSR, is defective. T h e patients seem to have a milder phenotype, although requiring intravenous immunoglobulin substation, an observation which can be linked to the protective role of mutated, high-affinity immunoglobulins, even of the IgM isotype.
Conclusion
T h e delineation of the molecular basis of the different H I G M syndromes in humans have strongly enlightened our knowledge concerning the mechanisms involved in B-cell terminal differentiation necessary for efficient humoral immune response. 
